FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. - Wikidata - wikimedia - TriplyDB

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

http://www.wikidata.org/entity/Q35272291

about

Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study FGF23 in Acute and Chronic Illness The role of phosphorus in the development and progression of vascular calcification Immune dysfunction in uremia—an update Fibroblast growth factor 23 Cardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular Disease Calcium and phosphate impact cardiovascular risk.FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney disease.Fibroblast Growth Factor-23-A Potential Uremic Toxin Worsening endothelial function with efavirenz compared to protease inhibitors: a 12-month prospective study Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.MICS, an easily ignored contributor to arterial calcification in CKD patients.Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease Prognostic value and link to atrial fibrillation of soluble Klotho and FGF23 in hemodialysis patients.Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC).Higher fibroblast growth factor-23 concentrations associate with left ventricular systolic dysfunction in dialysis patients Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients.Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis.Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4 Soluble klotho may be a marker of phosphate reabsorption.FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts.The use of fibroblast growth factor 23 testing in patients with kidney disease.Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline.Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).Vascular calcification in chronic kidney disease: role of disordered mineral metabolism.Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate.Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort.Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia.Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1.Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs).Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.Fibroblast growth factor 23 and incident CKD in type 2 diabetes.Circulating fibroblast growth factor 23 is associated with angiographic severity and extent of coronary artery disease.Fibroblast growth factor 23 and risk of incident stroke in community-living adults Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study.The impact of acute kidney injury on the long-term risk of stroke.Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.Vitamin D resistance in chronic kidney disease (CKD).

P2860

Q22306543-A4B4F7CF-F8C8-4F1C-9E28-E4032849A46A Q26778554-FA1C52EC-C203-4EEE-9FCF-749E8BBA1015 Q26823897-3A6BBFD0-8227-47BC-9C10-C2AE8E8E17B1 Q26829076-4CF0A578-9719-43FA-A99B-3EA197CCE2DA Q26829294-FF24EFAE-B190-44A2-8DA4-E70619A016D7 Q27024043-4AD2FED9-8DE5-4123-BDF2-30125A32B6A3 Q27687570-7224A61A-F522-4476-AF49-D1E955C407B2 Q27687769-8418D428-2712-432F-BF19-38F2250006EA Q28075648-81DA5EBE-A1D6-43E3-9C4F-ED6261E8CB63 Q28483914-C8208FB8-FFA8-49EC-B42F-D254DB2E1D3F Q30234797-19C3BC72-A4C8-4165-A141-88C2A2CC4CDB Q30249410-A4340B2F-E3D8-4A08-A87D-972BDD03565F Q30658399-477E07DB-B908-4903-A136-FD08D77E73D3 Q31171853-7B33934B-7DF7-4814-A76E-9FF6D3B8A22C Q33591588-C08DABD9-B4B0-4D0A-867D-CAA4056D6AC6 Q33600110-9DBE32CC-52AE-45BE-8CA3-7844A0D7813C Q33625482-C1A0A112-4F5D-4F6B-934A-5E7C1D5063C6 Q33650866-E36C5A68-82DB-485B-BE79-9AFC96DCB188 Q33715785-C4431DA3-71E2-4535-AA59-B1DB0D55CEDE Q33783120-62CC3D86-7AB6-4E55-994E-659CF7F5FE30 Q33793927-7B418E32-3582-4DF6-A226-1D8411CAB606 Q33835743-D275632B-5F7D-4C2B-9819-451533BE4C4B Q33873450-1342D9E6-0F74-49A7-8BD1-21001C886465 Q33937415-155727ED-3DBF-4A3B-8715-66A715201A89 Q33940724-1422A14D-7285-44A6-9127-C6976A72895E Q34037021-68A320B7-A6E6-4677-863E-6E795223073C Q34054004-F655CE7C-D3E5-4F0A-9C48-1A99037BC190 Q34244300-0F4A59C0-9362-49F5-9604-4052433BE136 Q34557041-1DC86D83-7CA6-40F3-A42D-25CDEF5B3014 Q34603360-EB399EEF-4639-4A49-90DA-E5BB59C51507 Q34634066-8EC89B5B-3AB0-4484-BF70-A83CD7995521 Q34669005-2E99CA77-949A-4FD9-B031-DD7312634B5E Q34794004-CF64A8F7-4412-41E5-AECF-069A39C43FD0 Q34828731-0C5825A4-CF17-49D0-841C-992E4E577F76 Q34981550-8FB6EE55-6D45-4D49-B4E0-A6CAFE5DD438 Q35019943-125DE89B-5DC3-4D8D-AA1C-24263ABA2A4A Q35021985-9315ACEF-EBC9-489E-9890-14B5C1C261D5 Q35026274-ECD7CE66-4D65-4139-B607-C5B12A724A84 Q35067500-000602EB-8BE0-43B7-B198-11AC101D48F0 Q35123615-F26CA904-6DA0-44B9-BA1D-B7E87BC0AE5F

P2860

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

http://www.wikidata.org/entity/Q35272291

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

@ast

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

@en

type

label

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

@ast

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

@en

prefLabel

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

@ast

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

@en

P1433

Q35272291-F7B9D157-9954-43BC-BD42-2FB88F29A166

P1476

Q35272291-6DD4AC77-5FF9-4006-9F00-DC4867D1470A

P2093

Q35272291-2CBE5810-0EF6-4FEE-936D-F752567B599E

Q35272291-32EF3EF3-8AF5-43B2-8FF1-E532F1DCC292

Q35272291-68D6A30D-DB29-49B9-B1BE-91B30224BD89

Q35272291-6C03F602-95A9-46BE-8D60-1530C3BA45B1

Q35272291-6F4A62FC-7674-4AEC-8B26-DDD24B356569

Q35272291-A2D12F11-2017-4102-BDF8-CEA362C58B12

Q35272291-C68CF6D3-E674-4947-AC07-51F868EE1D06

Q35272291-F941CB5C-EEB3-4A09-9AD5-32F0DC8DD25D

P2860

Q35272291-109F3523-03EC-484E-B1FE-A6478193E4D8

Q35272291-151AFF0D-1320-49B3-BE43-727800EC2B43

Q35272291-2AE97555-D62E-465E-B4B9-35F677D483C4

Q35272291-3AC95177-7EE9-498B-AA0D-4AFFC6F98646

Q35272291-3C1D2882-7001-4502-A5A5-F66C9ED0C261

Q35272291-40853437-C510-443D-9503-2BC0B564BB62

Q35272291-41427963-65B4-449B-B33D-EE1386C7D321

Q35272291-629B9F90-1164-46DC-A526-44C5E417B263

Q35272291-69430A04-A121-47A1-9FEE-315ECCC51C93

Q35272291-69B1B57C-00C2-46C0-B9E8-4406F1086571

P304

Q35272291-CCA73BFE-DADE-4530-8EC3-9D7C01643E6F

P31

Q35272291-090081D5-6504-453C-BF25-BEFA0300468C

P356

Q35272291-6647B19C-71EF-4FC4-ADD0-7A784309E37E

P433

Q35272291-5939B7EF-AE33-4751-8796-CAC21AEF43DB

P478

Q35272291-4FE3F066-E340-43C4-BBE8-ED88A322A598

P577

Q35272291-4A06FF9D-8551-421E-A3C0-3955B5A654EF

P698

Q35272291-557C9CB6-255C-4516-A3EE-E3FBD1199E90

P921

Q35272291-2F2A56E3-49CC-4136-8643-51D60F0AC9EF

Q35272291-C25DD058-1FE5-48FB-98ED-5A58FBE13ECC

P932

Q35272291-B42C781D-216A-419F-8167-1E8684745B29

P356

P1433

Journal of the American Society of Nephrology

P1476

FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis.

@en

P2093

Alfred K Cheung

http://www.w3.org/2001/XMLSchema#string

Gerard Smits

http://www.w3.org/2001/XMLSchema#string

HOST Investigators

http://www.w3.org/2001/XMLSchema#string

James S Kaufman

http://www.w3.org/2001/XMLSchema#string

Jessica Kendrick

http://www.w3.org/2001/XMLSchema#string

Michel Chonchol

http://www.w3.org/2001/XMLSchema#string

Tom Greene

http://www.w3.org/2001/XMLSchema#string

William L Roberts

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo

Prevalence of chronic kidney disease in the United States

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.

Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

Phosphorus binders and survival on hemodialysis.

P304

1913-1922

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2010121224

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21903574

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

3187186

http://www.w3.org/2001/XMLSchema#string